We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$21.6B
AUM Growth
+$3.73B
Cap. Flow
+$2.14B
Cap. Flow %
9.89%
Top 10 Hldgs %
20.71%
Holding
1,837
New
181
Increased
1,318
Reduced
286
Closed
50

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34M
2
XOM icon
ExxonMobil
XOM
+$33.1M
3
JNJ icon
Johnson & Johnson
JNJ
+$32.7M
4
MMM icon
3M
MMM
+$32.4M
5
MCD icon
McDonald's
MCD
+$32.3M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Financials 12.4%
3 Industrials 11.69%
4 Healthcare 11.57%
5 Consumer Staples 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGOV
1476
DELISTED
NIC Inc
EGOV
$240K ﹤0.01%
+10,755
New +$235K
COLL icon
1477
Collegium Pharmaceutical
COLL
$1.14B
$239K ﹤0.01%
11,617
-1,105
-9% -$18.4K
THRM icon
1478
Gentherm
THRM
$1.31B
$239K ﹤0.01%
+5,382
New +$229K
THS
1479
DELISTED
Treehouse Foods
THS
$239K ﹤0.01%
4,937
+555
+13% +$28.4K
TSE
1480
DELISTED
Trinseo
TSE
$239K ﹤0.01%
6,420
+789
+14% +$32.1K
FLR icon
1481
Fluor
FLR
$7.29B
$238K ﹤0.01%
12,600
+1,367
+12% +$24.8K
AA icon
1482
Alcoa
AA
$11.7B
$237K ﹤0.01%
11,015
-1,293
-11% -$26.8K
ILPT
1483
Industrial Logistics Properties Trust
ILPT
$613M
$237K ﹤0.01%
+10,580
New +$227K
VBTX
1484
DELISTED
Veritex Holdings
VBTX
$237K ﹤0.01%
+8,119
New +$209K
HTH icon
1485
Hilltop Holdings
HTH
$2.29B
$236K ﹤0.01%
+9,479
New +$231K
STOK icon
1486
Stoke Therapeutics
STOK
$1.82B
$236K ﹤0.01%
+8,317
New +$209K
URGN icon
1487
UroGen Pharma
URGN
$2B
$236K ﹤0.01%
+7,077
New +$193K
TWNK
1488
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$236K ﹤0.01%
16,202
+2,588
+19% +$35.2K
CTB
1489
DELISTED
Cooper Tire & Rubber Co.
CTB
$236K ﹤0.01%
+8,217
New +$232K
MEI icon
1490
Methode Electronics
MEI
$543M
$235K ﹤0.01%
+5,974
New +$217K
STNG icon
1491
Scorpio Tankers
STNG
$3.96B
$235K ﹤0.01%
+5,978
New +$205K
USPH icon
1492
US Physical Therapy
USPH
$1.14B
$235K ﹤0.01%
2,055
+299
+17% +$37.2K
APPF icon
1493
AppFolio
APPF
$5.85B
$234K ﹤0.01%
+2,131
New +$217K
HTLF
1494
DELISTED
Heartland Financial USA, Inc.
HTLF
$234K ﹤0.01%
+4,714
New +$222K
CYTK icon
1495
Cytokinetics
CYTK
$11B
$233K ﹤0.01%
21,947
-1,763
-7% -$18.1K
EPAC icon
1496
Enerpac Tool Group
EPAC
$1.77B
$233K ﹤0.01%
+8,937
New +$218K
AYX
1497
DELISTED
Alteryx Inc
AYX
$233K ﹤0.01%
2,324
+134
+6% +$13.6K
FCF icon
1498
First Commonwealth Financial
FCF
$2.12B
$232K ﹤0.01%
15,971
+2,329
+17% +$32.7K
LZB icon
1499
La-Z-Boy
LZB
$1.59B
$232K ﹤0.01%
7,357
+1,065
+17% +$35.7K
NTLA icon
1500
Intellia Therapeutics
NTLA
$1.5B
$232K ﹤0.01%
15,812
-1,822
-10% -$25.4K

Similar funds

ProShare Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, ProShare Advisors held 1,837 positions worth $21.6B, up 21% from $17.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

ProShare Advisors deployed $2.14B of net new capital in Q4 2019, opening 181 new positions and adding to 1,318 existing holdings. Its largest new stake was Pennant Group: 484,308 shares worth $16M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was W.R. Berkley, an estimated $12.8M trimmed.

  • ProShare Advisors's largest Q4 2019 buy was Pennant Group: 484,308 shares worth $16M.
  • ProShare Advisors added most to Alphabet (Google) Class A in Q4 2019, an estimated $34M increase.
  • ProShare Advisors's biggest Q4 2019 reduction was W.R. Berkley, cutting an estimated $12.8M.
  • ProShare Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $70M.
  • ProShare Advisors's ten largest holdings make up 21% of its $21.6B portfolio in Q4 2019.
  • ProShare Advisors opened 181 new positions and closed 50 in Q4 2019.
  • ProShare Advisors's portfolio value rose 21% quarter-over-quarter to $21.6B.

Based on ProShare Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.